The second paper from #ASCO2022 #ASCO22 that I break down
This is one of the most technical papers I breakdown on the channel
CT DNA used to omit chemo in Stage II colon cancer
Read the book Malignant if you learn from this
Watch the YouTube Figures https://youtu.be/QxOBIi7I2BU

4.64 - DETERMINATION - Should we still use transplant Myeloma?

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com